ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
Risk Signals
24759 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ROCHE DIAGNOSTICS LIMITED
Live alerts from global media, monitored by Business Radar
2025-07-10 (dailyhealthindustry.it)
10 Luglio 2025 – Pagina Array – Daily Health Industry
In a country that focuses on competitiveness and innovation to build its future, the biotech sector is confirmed as a pillar of the Italian economy. This is demonstrated by the first impact study carried out with the methodological support of PWC Italia and which analyzes the value generated by a pharmaceutical company, Roche, in four areas: economics, research, work and environment. The results were ...
Read more2025-07-10 (tt.se)
Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research | Business Wire
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced a groundbreaking study published in the journal Science that utilized Parse's single cell technology to uncover how signaling pathways drive the formation of diverse neuron cell subtypes. By linking specific signals to cell fate outcomes, this research provides a powerful framework for generating defined cell types in vitro, which has broad relevance to human biology, disease, and therapeutic development. Principle investigators Dr. Barbara Treutlein, Head of the Quantitative Development Biology Lab at ETH Zurich, and Dr. Gray Camp, Group Leader at the Institute of Human Biology at Roche, led the experiment. Through an elegantly designed screening approach spanning 480 morphogens across 700,000 cells, the research team was able to explore how different morphogens interact with pro-neural transcription factors, thereby generating pure populations of different types of neu
Read more
2025-07-10 (elsiglofuturo.es)
El Siglo Future - Biotech, from Roche 700 million contribution to Italian GDP
Every euro of direct added value generates 2.26 per economy
Read more2025-07-10 (koreabiomed.com)
Korean health agency recognizes HER2 companion diagnostic tests as Level 2 reimbursement target < Policy < Article -
The Health Insurance Review and Assessment Service (HIRA) has officially determined that the "Level 2" companion diagnosis reimbursement is appropriate for the HER2 (Human Epidermal growth factor Receptor 2) companion diagnostic immunohistochemical (IHC) test, which has been a key concern for pathol
Read more2025-07-10 (metro.co.uk)
Prime Day sees huge sale on SPF from Simple, La Roche Posay and more | News
There are some unmissable discounts across SPF for face and body - including top brands like Heliocare, Simple, Altruist and La Roche Posay
Read more2025-07-10 (7info.ci)
What are the cancers that kill the most in Côte d'Ivoire?
What are the deadliest cancers in Côte d'Ivoire? In 2022, more than 14,000 deaths were recorded. Discover the most frequent.
Read more
2025-07-10 (economymagazine.it)
Biotech and growth: Roche's multiplier effect on the Italian economy
The biotechnological sector is confirmed as one of the strategic joints for the economic growth of Italy. Roche's activity is concrete,
Read more2025-07-10 (ilfarmacistaonline.it)
The online pharmacist: pharmaceutical. From Roche over 700 million euros the contribution to GDP and effects on work, research and environment
Science and drugs
Read more2025-07-10 (affaritaliani.it)
All about: Roche Pil - .it
Roche, presented the first study on the impact in Italy: over € 700 million contribution to GDP
Read more2025-07-09 (vanguardiadesevilla.com)
A tested treatment in the Virgen del Rocío reduces 27% the risk of death from microcytic lung cancer
Bernabé explained that the type of cancer treated is 'a lung cancer of small cells characterized by its rapid growth and the aggressiveness of the tumor'. ...
Read more2025-07-09 (diariomedico.com)
Farmaindustria demands a ministerial order to evaluate health technology
'The new framework for the evaluation of innovative medicines in Spain', an organized course by Roche, has approached the RD of Health Technologies.
Read more2025-07-09 (nymag.com)
Levi's, Logitech, La Roche-Posay: All for $25 or Less This Prime Day
Our writer found the best Amazon Prime Day deals for under $25, including discounts on beauty, fashion, wellness, kitchen, and tech products.
Read more